SciELO - Scientific Electronic Library Online

 
vol.39 número2Rehabilitación en la enfermedad de PompeSistema glinfático: aspectos anatómicos, fisiológicos e implicaciones clínicas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Acta Neurológica Colombiana

versión impresa ISSN 0120-8748versión On-line ISSN 2422-4022

Resumen

CARDENAS-ROBLEDO, Simon; ENRIQUE-RUANO, Pilar; GUIO-SANCHEZ, Claudia  y  LOPEZ-REYES, Lorena. COVID-19 in patients with multiple sclerosis: retrospective observational study in a reference center in Colombia. Acta Neurol Colomb. [online]. 2023, vol.39, n.2, e7.  Epub 18-Ene-2024. ISSN 0120-8748.  https://doi.org/10.22379/anc.v39i2.1446.

Introduction:

The information about the frequency of COVID-19 and its outcomes in people with Multiple Sclerosis (MS) in Colombia is practically non-existent. We aimed to describe the frequency characteristics and factors associated with of COVID-19 in a sample of patients with MS.

Materials and methods:

Descriptive and retrospective analysis of patients diagnosed with Multiple Sclerosis criteria who attended our center between June and October 2021. Patients provided information about SARS-CoV-2 infection and their vaccination. COVID-19 determinants were analyzed using uni-and multivariable binomial logistic regression models.

Results:

240 patients were analyzed, of whom 71% were women, with a mean age of 34 years. The majority of patients were on disease-modifying therapies and over 80 % were vaccinated. 69 patients reported having had COVID-19. In multivariable models, age (OR 0.96; 95 % CI 0.93-0.99) was the only factor associated with a lower odds of COVID-19 infection.

Discussion:

COVID-19 infection in patients with MS in Colombia appears to be independent of clinical and treatment variables, and it appears to be associated with younger age.

Conclusions:

More studies are needed to assess the behavior of COVID-19 in MS patients from Colombia.

Palabras clave : Multiple sclerosis; Covid-19; SARS-CoV-2; Covid-19 vaccines; Covid-19 breakthrough infections; Immunosuppression therapy.

        · resumen en Español     · texto en Español     · Español ( pdf )